Sort
15,842 grants matching “pancreatic cancer”
Porcine Platforms For Technology Development In Pancreatic Cancer
$635,749Michael A Hollingsworth · University Of Nebraska Medical Center · R01 · FY2025 · CA
Immunobiology and immunotherapy of pancreatic cancer
$635,533Robert H Vonderheide · University Of Pennsylvania · R01 · FY2015 · CA
Stomal Senescence Regulator of Tumor Immunity and Progression
$634,970David G Denardo · Washington University · R01 · FY2025 · CA
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma
$634,470Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2018 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$634,454Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2021 · CA
Flexible Tools for Pre-Clinical Studies to Answer Key Questions UnderlyingHeavy-Ion Radiotherapy
$634,392David Jonathan Brenner · Columbia University Health Sciences · U01 · FY2019 · CA
Spatial Patterning in the Progressing Tumor - The Role of Notch
$634,151Herbert Levine · William Marsh Rice University · · FY2016 · MPS
Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics
$634,106Mark N Shahan · Quintessence Biosciences, Inc. · R44 · FY2009 · CA
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
$634,023Vadim Backman · Northwestern University · R01 · FY2017 · CA
Three-dimensional organoid culture using the CellRaft microwell technology
$633,892Jessica Hartman · Cell Microsystems, Inc. · R44 · FY2020 · ES
Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance
$633,787Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Administrative Core
$633,675Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
$633,669Douglas Faigel · Mayo Clinic Arizona · R01 · FY2016 · CA
Novel CAR T cell engineering strategies for effective eradication of solid and liquid tumors
$633,633Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2025 · CA
Overcoming anti-PEG immunity to restore prolonged circulation and efficacy of PEGylated therapeutics
$633,547Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2018 · HL
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
$632,643Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2015 · CA
Peptide-based targeted molecular imaging for early detection in pancreatic cancer
$632,421Julie L Sutcliffe · University Of California At Davis · U01 · FY2020 · CA
Targeting B7-H3 in ovarian cancer
$632,310Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$632,039Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images
$631,999Debiao Li · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$631,889Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
Inhibiting Multi-Functional ALDOA for Cancer Therapy
$631,803Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Project 3: Regulatory RNAs as Cancer Drivers and Dependencies
$631,452David L Spector · Cold Spring Harbor Laboratory · P01 · FY2024 · CA
Designing a Plan of Action for Better Access and Quality of Surgery for African-Americans with Gastrointestinal Cancers in the Deep South
$631,122Selwyn M Vickers · University Of Alabama At Birmingham · R01 · FY2020 · MD
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$631,044Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2021 · CA